Semen-derived amyloid fibrils drastically enhance HIV infection
about
Extensive complement-dependent enhancement of HIV-1 by autologous non-neutralising antibodies at early stages of infectionEfficacy of Carraguard-based microbicides in vivo despite variable in vitro activityThe soluble serum protein Gas6 bridges virion envelope phosphatidylserine to the TAM receptor tyrosine kinase Axl to mediate viral entryPeptides derived from HIV-1 gp120 co-receptor binding domain form amyloid fibrils and enhance HIV-1 infectionFibrils of prostatic acid phosphatase fragments boost infections with XMRV (xenotropic murine leukemia virus-related virus), a human retrovirus associated with prostate cancerPotential Use of Antimicrobial Peptides as Vaginal Spermicides/MicrobicidesBlocking HIV-1 transmission in the female reproductive tract: from microbicide development to exploring local antiviral responsesAnimal and human mucosal tissue models to study HIV biomedical interventions: can we predict success?Predominant Role of Plasmacytoid Dendritic Cells in Stimulating Systemic AutoimmunityHIV, sexual violence and special populations: adolescence and pregnancyAdvances in HIV microbicide developmentUbiquitous amyloidsThe regulation of inflammatory pathways and infectious disease of the cervix by seminal fluidNMR Structure in a Membrane Environment Reveals Putative Amyloidogenic Regions of the SEVI Precursor Peptide PAP 248−286Structure-based design of non-natural amino-acid inhibitors of amyloid fibril formationHIV Cell-to-Cell Spread Results in Earlier Onset of Viral Gene Expression by Multiple Infections per CellBottlenecks in HIV-1 transmission: insights from the study of founder virusesEvidence and controversies on the role of XMRV in prostate cancer and chronic fatigue syndromePolyanionic candidate microbicides accelerate the formation of semen-derived amyloid fibrils to enhance HIV-1 infectionDevelopment of HIV-1 rectal-specific microbicides and colonic tissue evaluationColorectal mucus binds DC-SIGN and inhibits HIV-1 trans-infection of CD4+ T-lymphocytesPostcoital bioavailability and antiviral activity of 0.5% PRO 2000 gel: implications for future microbicide clinical trialsThe synthetic bacterial lipopeptide Pam3CSK4 modulates respiratory syncytial virus infection independent of TLR activationFetal Growth Restriction Caused by Sexual Transmission of Zika Virus in Mice.Silk fibroin-derived nanoparticles for biomedical applications.Direct visualization of HIV-enhancing endogenous amyloid fibrils in human semen.Structural and functional analysis of human prostatic acid phosphatase.The integrated HIV-1 provirus in patient sperm chromosome and its transfer into the early embryo by fertilization.Mucosal transmission of human immunodeficiency virusMicrobicides and HIV: A Review and an update.The C-terminal amyloidogenic peptide contributes to self-assembly of Avibirnavirus viral proteaseCan a topical microbicide prevent rectal HIV transmission?Seminal plasma induces inflammation and enhances HIV-1 replication in human cervical tissue explants.Influence of dendritic cells on viral pathogenicityThermodynamic selection of steric zipper patterns in the amyloid cross-beta spineHuman erythrocytes selectively bind and enrich infectious HIV-1 virions.Exposure to HIV-1 directly impairs mucosal epithelial barrier integrity allowing microbial translocationThe Surprising Role of Amyloid Fibrils in HIV InfectionElevation of intact and proteolytic fragments of acute phase proteins constitutes the earliest systemic antiviral response in HIV-1 infectionAminoquinoline surfen inhibits the action of SEVI (semen-derived enhancer of viral infection).
P2860
Q21245045-3C7E5723-C3DD-46A2-843D-A62CCC5ED972Q21562543-8E65210D-BD9B-42A6-A29B-5D9DD2FAF14FQ24299966-6959C641-F9F3-47FB-B512-2100CB0BE961Q24339532-D6FF762F-051E-4868-9725-F1A922D0EB52Q24654629-914CE16A-3CF4-4D71-875B-F7E9321091F2Q26765450-A342497B-EF38-4656-9335-05F4BBBE8864Q26774878-BC403170-622C-4B2F-AAE3-29B4A399F12CQ26777022-935BC1F0-DEB7-4E92-AF32-1B37ECF232F0Q26777199-75130D3F-FB3A-4C5B-9820-B0927508D266Q26825943-125E2299-F05B-4CAD-BD1D-C08B08A412FBQ26852858-E03BB91E-D3AD-4A39-8988-20BC3AFADC9BQ27016014-EE4CCBA7-A40E-4ED9-9B4C-C920EED95067Q27024447-54B3E297-12EF-437E-B27F-0BE293673637Q27658538-C362B37E-483D-4CF2-A58F-F68610C3E0D2Q27670453-41E53AB8-AB9B-481C-8C63-6541F691BDA4Q27681313-7EA9C3A5-C6D1-4B1F-BADA-0A024205E2FBQ28082862-1AA67E26-E393-4592-AB00-D7FD7D362DAFQ28304673-E076CDAD-3D8A-429A-9840-4A42A352F07EQ28489042-099D0D88-3F81-411C-9BC9-35F2FD2A2A2CQ28540761-23321499-B4D7-43C8-8709-7983A8B692FBQ28544754-12C3314B-214B-425E-BA6A-65EBA8428350Q28749211-9865ED69-580D-4AFF-909A-E52CB139A1C4Q28749631-1F0844F2-175A-498A-935B-BA1F8450D7C8Q30145649-094CF590-F7AC-47E7-86B8-288CA6C26487Q30156091-B4132070-86BC-4E61-9C02-C57D8E4FD457Q30360888-553CFBA8-C3D9-4FF0-8C67-365C713A3175Q30391641-E033E313-5101-4A0F-9FCD-8ABE6AFAB643Q30411013-2D3B49F7-B737-46A4-B72F-9516C493239EQ30412036-14886667-A8BE-4BF3-812B-0A6638276592Q30424145-90327547-E3B0-4846-87AA-2115F9E9A7AEQ30666918-353822ED-C067-41AA-8514-4142DB2CF056Q33358267-62B15DD0-B375-432E-957F-8FB90D50FACBQ33390855-23164105-55EB-4E18-AFC6-03276D4ADF46Q33489629-E349FD17-9530-4747-A220-9FA8679D9286Q33500126-C086851B-E27D-4D5A-814D-73FC319A04ECQ33518534-BEDADDDB-200D-4817-B90F-E5D2E5D3082BQ33553358-358B9562-408D-449D-AF25-9F410269D178Q33570363-4BAF02C3-3386-4A8C-A6AF-21D23E420BDDQ33576664-91397502-2738-4DFF-B651-958853643449Q33581944-47FA5717-4F60-4F1C-9A87-4AE2CAF15AED
P2860
Semen-derived amyloid fibrils drastically enhance HIV infection
description
2007 nî lūn-bûn
@nan
2007 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2007 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
name
Semen-derived amyloid fibrils drastically enhance HIV infection
@ast
Semen-derived amyloid fibrils drastically enhance HIV infection
@en
Semen-derived amyloid fibrils drastically enhance HIV infection
@en-gb
Semen-derived amyloid fibrils drastically enhance HIV infection
@nl
type
label
Semen-derived amyloid fibrils drastically enhance HIV infection
@ast
Semen-derived amyloid fibrils drastically enhance HIV infection
@en
Semen-derived amyloid fibrils drastically enhance HIV infection
@en-gb
Semen-derived amyloid fibrils drastically enhance HIV infection
@nl
prefLabel
Semen-derived amyloid fibrils drastically enhance HIV infection
@ast
Semen-derived amyloid fibrils drastically enhance HIV infection
@en
Semen-derived amyloid fibrils drastically enhance HIV infection
@en-gb
Semen-derived amyloid fibrils drastically enhance HIV infection
@nl
P2093
P50
P3181
P1433
P1476
Semen-derived amyloid fibrils drastically enhance HIV infection
@en
P2093
Anke Specht
Christine Goffinet
Devi Rajan
Douglas M Fowler
Elke Rücker
Knut Adermann
Leonid Margolis
Michael Schindler
Oliver T Keppler
P304
P3181
P356
10.1016/J.CELL.2007.10.014
P407
P50
P577
2007-12-14T00:00:00Z